Newsroom

Dirk Heinz und Josef Penninger
News
In July of this year, the new Scientific Director, Prof Josef Penninger, took office at the Helmholtz Centre for Infection Research (HZI). He succeeds Prof Dirk Heinz, who stepped down from his position after 13 years and began establishing the new "Molecular Structural Biology" research department at the HZI. On 4 December 2023, Dirk Heinz was thanked for his many years of successful work and the handover of office to Josef Penninger was celebrated in the presence of renowned guests from science and politics.
05.12.2023
Press image
News
To ensure that vaccines provide strong and lasting immunization, it is often necessary to supplement the actual vaccine (antigen) with additives that stimulate the immune system: adjuvants. Today, only a few substances have been approved for use as adjuvants. In the journal Angewandte Chemie, a research team has now introduced a spectrum of potential adjuvants. They started with the immune stimulant α-glactosyl ceramide (α-GalCer) and synthesized many different variants from a set of four building blocks.
04.12.2023
Tabletten
News
The Federal Ministry of Education and Research (BMBF) is funding the establishment of a German-Ukrainian core of excellence to help discover new anti-infectives and make them available for medical purposes. The core of excellence, funded with 2.5 million euros, is to be located in the western Ukrainian city of Lviv - in collaboration with Saarland University and the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS). In the long term, the core of excellence should establish itself as an independent research institution and strengthen scientific relations between Germany and Ukraine. The HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in cooperation with Saarland University.
28.11.2023
AI Image symbolique, personne en blouse blanche avec stéthoscope en arrière-plan
News
Improving health care and strengthening personalized medicine: A new research center for Artificial Intelligence (AI) and causal methods in medicine (CAIMed - Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine) is being established in Lower Saxony. Researchers in computer science and medicine from Hannover, Göttingen and Braunschweig will develop innovative methods and applications of artificial intelligence. The Ministry of Science and Culture and the Volkswagen Foundation are providing 15 million euros from the joint "zukunft.niedersachsen" program for the next five years. Prof Wolfgang Nejdl from the L3S Research Centre at the Leibniz University of Hanover (LUH) will act as spokesperson. Two of the new research groups will be set up at sites of the Helmholtz Centre for Infection Research (HZI).
22.11.2023
Portrait of researchers
News
The list of “Highly-cited researchers” is published annually by Clarivate Analytics to honor scientists who have made a particularly significant impact in their fields. Five heads of department at the Helmholtz Centre for Infection Research (HZI) are among the honorees in 2023: bioinformaticians Prof Alice McHardy, Prof Yang Li and Prof Andreas Keller, biotechnologist Prof Marc Stadler and the Scientific Director of the HZI and geneticist Prof Josef Penninger were recognized for their scientific publications in the past year.
17.11.2023
chart
News
Sustainable and environmentally friendly production processes are playing an increasingly important role in almost all branches of industry. The production of active pharmaceutical ingredients in particular involves the use of various materials and reagents, many of which have environmentally harmful properties and therefore require costly processing and disposal. Researchers at the University of Graz and the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) have now succeeded in developing a strategy for the synthesis of active pharmaceutical ingredients from wood waste that does not involve any harmful starting materials or by-products. The team published its results in the journal Angewandte Chemie International Edition.
16.11.2023

HZI in the media

Die Schüler vom Greifswalder Alexander-von-Humboldt Gymnasium forschen in diesem Schuljahr zusammen mit Forschern ...

01.07.2024
|
Tagesschau

Sendung: NDR Info | 01.07.2024 | 14:00 Uhr

01.07.2024
|
NDR Norddeutscher Rundfunk

Um Viren für Impfstoffe zu inaktivieren, werden oft Gammastrahlen verwendet. Forscher aus Darmstadt und Braunschweig ...

30.06.2024
|
FAZ.NET

Für Neugeborene ist RSV lebensgefährlich, Winterkinder sollen auf der Entbindungsstation Antikörper bekommen © Getty Images Für ...

28.06.2024
|
MSN Deutschland

Neuer Ansatz zur DNA-Transformation und Genmutation in Bakterien entwickelt: Grundlage für neue Antibiotika und ...

28.06.2024
|
Bionity.COM

Respiratorische Synzytial-Viren (RSV) sind eine bedeutende Ursache für Atemwegsinfektionen, insbesondere bei Säuglingen und älteren ...

27.06.2024
|
ScienceMediaCenter